Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)

[1]  T. Wilt,et al.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2011 .

[2]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[3]  A. Bousvaros,et al.  2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  T. Shanafelt,et al.  Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia. , 2014, Journal of oncology practice.

[5]  Paolo Ghia,et al.  MBL versus CLL: how important is the distinction? , 2013, Hematology/oncology clinics of North America.

[6]  J. Cerhan,et al.  Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Cerhan,et al.  Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls , 2013, Leukemia.

[8]  J. Cerhan,et al.  Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  T. Shanafelt,et al.  Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population , 2012, Leukemia.

[10]  L. Pecciarini,et al.  General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL. , 2011, Blood.

[11]  R. Foà,et al.  Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group , 2011, Haematologica.

[12]  J. Cerhan,et al.  Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. , 2011, International journal of molecular epidemiology and genetics.

[13]  M. Tucker,et al.  Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  T. Shanafelt,et al.  Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management , 2010, Leukemia.

[15]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[16]  Deborah A. Bowen,et al.  Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  G. Jenkins,et al.  B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. , 2008, Blood.

[18]  H. Kantarjian,et al.  Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Bernadette Mazurek Melnyk,et al.  Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. , 2008, Annals of internal medicine.

[20]  S. Richards,et al.  Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. , 2008, The New England journal of medicine.

[21]  Michael Hallek,et al.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.

[22]  G. Jenkins,et al.  Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia , 2008, Leukemia & lymphoma.

[23]  Deborah A. Bowen,et al.  Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia , 2007, British journal of haematology.

[24]  C. Pipper,et al.  Risk of second cancer after chronic lymphocytic leukemia , 2007, International journal of cancer.

[25]  Paolo Ghia,et al.  Diagnostic criteria for monoclonal B‐cell lymphocytosis , 2005, British journal of haematology.

[26]  G. Guida,et al.  Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. , 2004, Blood.

[27]  Michael J. Green,et al.  Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. , 2002, Blood.

[28]  M. Greene,et al.  Solid tumors after chronic lymphocytic leukemia. , 2001, Blood.

[29]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[30]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[31]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[32]  T. Habermann,et al.  Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. , 1994, Mayo Clinic proceedings.

[33]  R. Gray.  A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[34]  B. Weinerman,et al.  Subsequent neoplasia in chronic lymphocytic leukemia. , 1975, JAMA.